24 Stocks Moving in Monday's Pre-Market Session

Gainers

• Dova Pharmaceuticals, Inc. DOVA shares rose 38.8% to $27.96 in pre-market trading after the company agreed to be acquired by Orphan Biovitrum for $29 per share.
• Mallinckrodt plc MNK shares rose 14.2% to $2.57 in pre-market trading after the company announced it settled opioid cases in Cuyahoga and Summit counties in Ohio.
• Checkpoint Therapeutics, Inc. CKPT shares rose 12% to $2.80 in pre-market trading after the company announces presentation of positive interim clinical results for anti-PD-L1 Cosibelimab at the European Society for Medical Oncology (ESMO) Congress 2019.
• Colony Capital, Inc. CLNY rose 10.2% to $6.50 in pre-market trading after the company announced it would sell its industrial real estate portfolio to Blackstone for $5.9 billion.
• Calithera Biosciences, Inc. CALA rose 9% to $3.54 in pre-market trading. Calithera Biosciences announced data from randomized Phase 2 ENTRATA study demonstrate telaglenastat with everolimus improves progression-free survival in renal cell carcinoma at ESMO 2019.
• LAIX Inc. LAIX rose 8.3% to $4.55 in pre-market trading.
• Atreca, Inc. BCEL rose 7.9% to $12.00 in pre-market trading after falling 14.46% on Friday.
• Myovant Sciences Ltd. MYOV shares rose 6.8% to $5.54 in pre-market trading.
• Bandwidth Inc. BAND rose 5.9% to $69.04 in pre-market trading.
• Thor Industries, Inc. THO rose 5.8% to $51.77 in pre-market trading after the company reported better-than-expected earnings for its fourth quarter.
• Teradyne, Inc. TER rose 5.7% to $60.68 in pre-market trading.
• Bed Bath & Beyond Inc. BBBY rose 4.7% to $10.35 in pre-market trading. Wedbush upgraded Bed Bath & Beyond from Neutral to Outperform and raised the price target from $14 to $16.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

• Globus Maritime Ltd GLBS shares fell 18% to $1.90 in pre-market trading. Globus Maritime reported a Q2 loss of $0.74 per share, versus a year-ago loss of $0.29 per share. Its sales slipped to $3.4 million from $4.194 million.
• Immunomedics, Inc. IMMU shares fell 9.2% to $13.00 in pre-market trading after interim data from the company's phase 2 study of Sacituzumab Govitecan showed a 29 percent response rate.
• Teekay LNG Partners L.P. TGP shares fell 9.1% to $13.75 in pre-market trading. Teekay Companies will postpone its investor day originally scheduled on Oct 2 to focus on Teekay LNG.
• Glaukos Corporation GKOS fell 5.9% to $57.55 in pre-market trading after dropping 7.85% on Friday.
• Ecopetrol S.A. EC fell 5.7% to $16.25 in pre-market trading.
• Mirati Therapeutics, Inc. MRTX fell 5.6% to $79.69 in the pre-market trading session.
• Catalyst Pharmaceuticals, Inc. CPRX fell 5% to $5.01 in the pre-market trading session.
• Teekay Corporation TK fell 4.3% to $4.05 in pre-market trading. Teekay Companies will postpone its investor day originally scheduled on Oct 2 to focus on Teekay LNG.
• Ooma, Inc. OOMA shares fell 4.1% to $10.45 in pre-market trading.
• ANGI Homeservices Inc. ANGI shares fell 3.7% to $6.80 in pre-market trading.
• 8x8, Inc. EGHT shares fell 3.5% to $20.59 in pre-market trading.
• Coeur Mining, Inc. CDE fell 3.4% to $5.03 in pre-market trading.